This relationship supports the hypothesis that much of tirzepatide's anti-inflammatory benefit may be mediated through weight loss rather than direct receptor-mediated anti-inflammatory signaling, though controlled studies specifically addressing this question are limited
Although prescriptions for weight-loss medication have increased for adolescents with obesity in the years since the AAP started recommending them, lifestyle treatment remains much more common, a study found
Patients appreciate knowing that the KwikPen mechanism is specifically engineered by Eli Lilly for ultimate convenience, featuring a crisp clicking system that prevents under-dosing or over-dosing
Some are, but with limitations: Liraglutide (Saxenda) is approved for weight management in adolescents aged 12-17 with obesity and a body weight above 132 pounds
Subcutaneous delivery suits both peptides: it gives a smooth absorption curve that fits the once-daily, pulse-timed design, and it keeps the injection itself low-volume at roughly a tenth of a millilitre
